Skip to Content

Boston Trust Walden SMID Cap WASMX Fund Analysis

| Medalist Rating as of | See Boston Trust Walden Investment Hub

Morningstar’s Analysis WASMX

Will WASMX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin Boston Trust Walden SMID Cap's Morningstar Medalist Rating of Gold.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor